Brian Goldstein > Choate, Hall & Stewart > Boston, United States > Lawyer Profile

Choate, Hall & Stewart
TWO INTERNATIONAL PLACE
BOSTON, MA 02110
MASSACHUSETTS
United States

Position

Brian Goldstein, co-chair of Choate’s Business & Technology Practice Group, has more than 30 years of experience advising venture capital and growth equity investors and innovative, high-growth companies in health IT, healthcare services, life sciences, and medical device industries, on their most important transactions and helping them to increase the returns on their investments.

Brian regularly advises on financings, strategic partnerships and licensing agreements, mergers and acquisitions, and general business counseling. His international practice includes cross-border financings and acquisitions, as well as advice on other U.S.-based activities, for companies headquartered or with significant operations in the United Kingdom/Ireland, Europe, and Israel.

Brian previously served as Assistant General Counsel at Groundwater Technology, Inc., where he handled SEC reporting; acquisitions, divestitures, and joint ventures; and the sale of a controlling interest of the company to Fluor Daniel.

Brian has advised sophisticated investment funds and globally-recognized investors and companies, including Answers Corp (WebCollage), Bain Capital Life Sciences, Perceptive Advisors (via Perceptive Xontogeny), Shire, and Transformation Capital.

Education

University of Virginia School of Law
JD, 1988
University of Virginia
BA, 1983, with honors

Lawyer Rankings

United States > M&A/corporate and commercial > Venture capital and emerging companies

Choate, Hall & Stewart has a strong focus on the investor side of the market, representing several leading venture capital and growth equity funds. The team regularly assists investors on every stage of the venture process, from seed and series A financings, later stage equity financings and onwards to IPO or sale. Clients also benefit from the firm’s broader expertise in related areas such as patent portfolio strategy, licensing and collaboration. The firm’s advice to Surveyor Capital, as co-investor on a $300 million series C investment into the biotech company Acelyrin, was a recent highlight. Partner Brian Goldstein  leads the largely Boston-based team and has especially good credentials on the life sciences and healthcare side. Tobin Sullivan also has a strong track record.

United States > M&A/corporate and commercial > M&A: middle-market (sub-$500m)

Based in Boston, Choate, Hall & Stewart offers representation to a host of acquirers, targets and investment banks in the context of public and private M&A  in the US and around the world. With particular strength in the private equity segment, the team is particularly well versed in corporate transactions involving tech and life sciences players, and often serves as US counsel to companies located in Canada, Israel, the UK and Ireland. John Pitfield is a reference for private and growth equity clients, most notably those with operations in the healthcare, life sciences and TMT sectors. He jointly leads the business and technology group with Brian Goldstein, who brings extensive experience advising venture capital investors and high-growth companies in the healthcare and IT industries. Corporate and securities attorney Tobin Sullivan advises life sciences and technology clients, ranging from start-ups to global public companies, on an array of transactional mandates.